Ribociclib and Letrozole Treatment in Ovarian Cancer
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The study evaluates the response to treatment with Ribociclib and Letrozole in patients with
low grade serous cancer of the ovary, fallopian tube or peritoneum.